U.S. orders 100 million doses of COVID-19 vaccine candidate from Pfizer and BioNTech


Pfizer and BioNTech have announced a nearly $2 billion agreement with the U.S. government for doses of a potential COVID-19 vaccine.
Under the agreement the companies detailed on Wednesday, the U.S. will get 100 million doses of a COVID-19 candidate after it's manufactured if it receives approval or authorization from the Food and Drug Administration. The U.S. will pay $1.95 billion for doses of the potential vaccine for Americans to receive for free and "also can acquire up to an additional 500 million doses," the announcement said.
"Depending on success in clinical trials, today's agreement will enable the delivery of approximately 100 million doses of this vaccine to the American people," U.S. Secretary of Health and Human Services Alex Azar said in a statement.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Albert Bourla, the CEO of Pfizer, recently expressed confidence in the company's coronavirus vaccine candidate, saying in an interview with Time it's "feasible" for it to potentially receive FDA approval in October "if we are lucky." On Wednesday, Pfizer and BioNTech said that depending on how studies of the vaccine go, they aim to "be ready to seek Emergency Use Authorization or some form of regulatory approval as early as October 2020." If that goes forward, they'll look to manufacture up to 100 million doses globally by the end of the year and "potentially more than 1.3 billion doses by the end of 2021."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Kirsty Coventry: the former Olympian and first woman to lead the IOC
In the Spotlight Coventry, a former competitive swimmer, won two Olympic gold medals
-
Critics' choice: Carrying the flag
Feature The best barbecue in town, Bradley Cooper's cheesesteak restaurant, and more
-
Film review: Materialists
Feature Two suitors seek to win over a jaded matchmaker
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments